{
    "eid": "2-s2.0-85022021364",
    "title": "Ixcellence network\u00ae: An international educational network to improve current practice in the management of cervical dystonia or spastic paresis by botulinum toxin injection",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        },
        {
            "$": "General Neuroscience",
            "@code": "2800"
        }
    ],
    "keywords": [
        "Botulinum toxin",
        "Cervical dystonia",
        "Spastic paresis",
        "Training"
    ],
    "authors": [
        "Klemens Fheodoroff"
    ],
    "citedby-count": 5,
    "ref-count": 31,
    "ref-list": [
        "Accessed September 2014. sociated with the development of antibodies against botulinum toxin? Allergol Immunopathol",
        "The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: An international survey",
        "Spasticity or reversible muscle hypertonia?",
        "Treatment of focal dystonia",
        "Expanding use of botulinum toxin",
        "Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: A systematic review",
        "Providing dementia outreach education to rural communities: Lessons learned from a Train-the-Trainer Program",
        "A statewide model detection and prevention program for geriatric alcoholism and alcohol abuse: Increased knowledge among service providers",
        "Survey of practices employed by neurologists for the definition and management of secondary nonresponse to botulinum toxin in cervical dystonia",
        "J Neuro Sci",
        "J Neuro Sci",
        "One Europe, one neurologist?",
        "Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders",
        "AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: An exploratory analysis of two large open-label extension studies",
        "Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia",
        "Dysport (botulinum toxin type A) in routine therapeutic usage: A telephone needs assessment survey of european physicians to evaluate current awareness and adherence to product labeling changes",
        "Botulinum toxin (Dysport\u00ae) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study",
        "Ixcellence Program",
        "Conflict of Interest in Medical Research, Education, and Practice",
        "Continuing medical education and the physician as a learner: Guide to the evidence",
        "Dysport Summary of Product Characteristics",
        "\u00d6sterreichische Dystonie- und Botulinumtoxin-Arbeitsgruppe",
        "What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport\u00ae",
        "Dystonias of the Neck: Clinico-Radiologic Correlations",
        "Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the american academy of neurologysymbol",
        "Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the american academy of neurologysymbol",
        "Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology",
        "Erratum: Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management (BMJ Open (2013) 3 (e002771))",
        "Upper limb international spasticity study: Rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice",
        "Continuing medical education committee and UEMS-EACCME",
        "The Science and Manufacturing Behind Botulinum Neurotoxin Type A-ABO in Clinical Use"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "affilname": "UCL Queen Square Institute of Neurology",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Boulogne-Billancourt",
            "affilname": "Ipsen",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Terni",
            "affilname": "Santa Maria University Hospital",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Alcabideche",
            "affilname": "Centro de Medicina de Reabilita\u00e7\u00e3o de Alcoit\u00e3o",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Hermagor",
            "affilname": "Gailtal-Klinik",
            "affiliation-country": "Austria"
        }
    ],
    "funding": []
}